Regulus Therapeutics
RGLS
$2.29
Share price
1.33%
Change (1 day)
76.15%
Change (1 year)
Categories
Market capitalization of Regulus Therapeutics (RGLS)
Market cap: $0.14 Billion
As of June 2024 Regulus Therapeutics has a market cap of $0.14 Billion. This makes Regulus Therapeutics the world's 7195th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Regulus Therapeutics from 2012 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $0.14 B | 479.16% |
| 2023 | $25.88 M | 12.2% |
| 2022 | $23.07 M | -49.82% |
| 2021 | $45.98 M | -46.37% |
| 2020 | $85.73 M | 358.29% |
| 2019 | $18.7 M | 127.96% |
| 2018 | $8.2 M | -92.41% |
| 2017 | $0.10 B | -9.21% |
| 2016 | $0.11 B | -74.07% |
| 2015 | $0.45 B | -41.5% |
| 2014 | $0.78 B | 154.23% |
| 2013 | $0.30 B | 36.8% |
| 2012 | $0.22 B |
End of Day market cap according to different sources
On May 31st, 2024 the market cap of Regulus Therapeutics was reported to be:
$0.14 Billion
$0.14 Billion
$0.14 Billion
$0.14 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | $122.54 B | 81,642.00% | 🇫🇷 France |
 Biogen BIIB | $32.75 B | 21,745.83% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $83.29 B | 55,459.81% | 🇺🇸 USA |
 AstraZeneca AZN | $241.89 B | 161,255.16% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $93.92 B | 62,550.33% | 🇬🇧 UK |
 Sangamo Therapeutics
SGMO | $0.11 B | -21.88% | 🇺🇸 USA |
 Dicerna Pharmaceuticals DRNA | $2.97 B | 1,886.23% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | $18.77 B | 12,423.74% | 🇺🇸 USA |